XML 29 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Revenues $ 0 $ 0 $ 0 $ 0
Ramp up of manufacturing costs 585 0 1,611 0
Gross loss 585 0 1,611 0
Operating expenses:        
Research and development 769 1,078 3,209 3,169
Marketing and pre-production costs 252 763 911 1,924
General and administrative 901 1,397 3,047 4,817
Total operating expenses 1,922 3,238 7,167 9,910
Operating loss 2,507 3,238 8,778 9,910
Financial expenses (income), net:        
Revaluation of warrants (2,606) 192 (3,144) 3,992
Other financial expense 3,176 41 3,681 83
Total financial expenses, net 570 233 537 4,075
Net loss 3,077 3,471 9,315 13,985
Deemed dividend related to exchange agreement (Note 4a) 279 0 279 0
Deemed dividend related to Series A Preferred Stock (Note 4b) 2,977 0 2,977 0
Net loss attributable to holders of Common Stock $ 6,333 $ 3,471 $ 12,571 $ 13,985
Net loss per share        
Basic loss per share $ (0.66) $ (0.85) $ (2.03) $ (3.95)
Weighted average number of Common Stock used in computing basic net loss per share 9,610,160 3,994,481 6,179,981 3,551,559
Diluted loss per share $ (0.66) $ (0.85) $ (2.23) $ (3.95)
Weighted average number of Common Stock used in computing diluted net loss per share 9,610,160 3,994,481 6,194,418 3,551,559